G-Protein Coupled Receptor 119 (GPR119) Antibody
416€ (200 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
G-Protein Coupled Receptor 119 (GPR119) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx432763
tested applications
P-ELISA, WB
Description
GPR119 Antibody is a Goat Polyclonal antibody against GPR119.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | G-Protein Coupled Receptor 119 (GPR119) |
| Host | Goat |
| Reactivity | Human |
| Recommended Dilution | P-ELISA: 1/2000. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Size 1 | 200 µl |
| Form | Liquid |
| Tested Applications | P-ELISA, WB |
| Buffer | Tris saline, pH 7.3, containing 0.02% sodium azide and 0.5% bovine serum albumin. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Gene ID | 139760 |
| NCBI Accession | NP_848566.1 |
| Alias | GPR119,GPCR2,glucose-dependent insulinotropic receptor,G-protein coupled receptor 2,G protein-coupled receptor 119 |
| Background | Antibody anti-GPR119 |
| Status | RUO |
| Note | Concentration: 0.5 mg/ml - |
Descripción
GPR119 is a G protein-coupled receptor primarily expressed in pancreatic β-cells and enteroendocrine cells in the gastrointestinal tract. It is activated by endogenous lipids such as oleoylethanolamide (OEA) and dietary-derived fatty acid derivatives. GPR119 plays a critical role in glucose homeostasis and energy metabolism by stimulating glucose-dependent insulin secretion from pancreatic β-cells and promoting the release of incretin hormones like glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) from intestinal cells. This dual action improves insulin sensitivity and regulates appetite, making GPR119 an attractive therapeutic target for type 2 diabetes and obesity. Activation of GPR119 leads to cAMP accumulation and downstream activation of insulinotropic pathways, enhancing glucose control without causing hypoglycemia. Dysregulation of GPR119 signaling has been associated with metabolic disorders, including insulin resistance and obesity. GPR119 agonists are currently being developed to improve glycemic control and promote weight loss, highlighting its significance in metabolic health.
Related Products
G Protein-Coupled Receptor 119 (GPR119) Antibody
GPR119 Antibody is a Rabbit Polyclonal against GPR119.
Ver Producto
G-Protein Coupled Receptor 119 (GPR119) Antibody
GPR119 Antibody is a Goat Polyclonal antibody against GPR119.
Ver Producto
Human Glucose-dependent insulinotropic receptor (GPR119) ELISA Kit
Human Glucose-dependent insulinotropic receptor (GPR119) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human Glucose-dependent insulinotropic receptor (GPR119) concentrations in tissue homogenates, cell lysates and other biological fluids.
Ver Producto